CyberKnife Radiosurgery for Organ-Confined Prostate Cancer: Homogenous Dose Distribution

Completed · Not applicable

Conditions studied: Prostate Cancer, Prostatic Cancer, Prostate Neoplasms, Prostatic Neoplasms, Cancer of the Prostate

In brief

The purpose of this study is to determine the effects of CyberKnife radiosurgery in patients with early stage organ-confined prostate cancer.

Key facts

Study ID

NCT00643994

Run by

Accuray Incorporated

People needed

379

Starts

2007-12-01

Expected to finish

2021-01-27

Last updated by the study team

2023-05-09

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Patient must be at least 18 years of age
• Histologically proven prostate adenocarcinoma
• Patients belonging in one of the following risk groups:
• Low: Clinical Stage (CS) T1b-T2a and Gleason 2-6 and Prostate Specific Antigen (PSA) ≤ 10, or Intermediate: CS T2b and Gleason 2-6 and PSA ≤ 10 or CS T1b-T2b, and Gleason 2-6 and PSA ≤ 20 ng/ml or Gleason 7 and PSA ≤ 10 ng/ml
• Prostate volume: ≤ 100 cc
• Eastern Cooperative Oncology Group (ECOG) performance status 0-1

You may not qualify if…

• Prior prostatectomy or cryotherapy of the prostate
• Prior radiotherapy to the prostate or lower pelvis
• Implanted hardware or other material that would prohibit appropriate treatment planning or treatment delivery, in the investigator's opinion
• Chemotherapy for a malignancy in the last 5 years
• History of an invasive malignancy (other than this prostate cancer, or basal or squamous skin cancers) in the last 5 years.
• Hormone ablation for two months prior to enrollment, or during treatment.

Where it is running

• St. Joseph's Hospital and Medical Center — Phoenix, Arizona, United States
• Scripps Cancer Center - CyberKnife of Southern California at Vista — La Jolla, California, United States
• The CyberKnife at Newport Diagnostic Center — Newport Beach, California, United States
• Georgetown University — Washington D.C., District of Columbia, United States
• Coastal CyberKnife and Radiation Oncology — Ft. Pierce, Florida, United States
• Jupiter Medical Center & CyberKnife Center of Palm Beach — Jupiter, Florida, United States
• Northwest Community Hospital — Arlington Heights, Illinois, United States
• Community Cancer Center — Normal, Illinois, United States
• Central Baptist Hospital — Lexington, Kentucky, United States
• Sinai Hospital of Baltimore — Baltimore, Maryland, United States
• Franklin Square Hospital Center — Baltimore, Maryland, United States
• Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States
• St. Joseph Mercy Hospital — Ann Arbor, Michigan, United States
• Lake Saint Louis Oncology — St Louis, Missouri, United States
• Saint Louis University — St Louis, Missouri, United States
• St. Mary's Regional Medical Center — Reno, Nevada, United States
• Capital Health — Trenton, New Jersey, United States
• Hematology Oncology Associates of Central New York — Syracuse, New York, United States
• Virginia Hospital Center — Arlington, Virginia, United States
• Swedish Cancer Center — Seattle, Washington, United States
• Southwest Washington Medical Center — Vancouver, Washington, United States
• Southwest Washington Regional Cancer Center — Vancouver, Washington, United States
• ThedaCare Appleton Medical Center — Appleton, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.